KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to -1.49%.

  • Dynavax Technologies' EBITDA Margin rose 992.00% to 22.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 737.00%. This contributed to the annual value of -1.49% for FY2024, which is 1445.00% up from last year.
  • Latest data reveals that Dynavax Technologies reported EBITDA Margin of -1.49% as of FY2024, which was up 90.67% from -15.94% recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' EBITDA Margin ranged from a high of 39.23% in FY2022 and a low of -146.87% during FY2020.
  • Its 3-year average for EBITDA Margin is 7.27%, with a median of -1.49% in 2024.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 23,600bps in 2020, then slumped by 5,517bps in 2023.
  • Yearly analysis of 5 years shows Dynavax Technologies' EBITDA Margin stood at -146.87% in 2020, then soared by 17,748bps to 30.60% in 2021, then spiked by 863bps to 39.23% in 2022, then crashed by 5,517bps to -15.94% in 2023, then skyrocketed by 1,445bps to -1.49% in 2024.